Literature DB >> 31900618

A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol.

Marilia Oliveira Morais1, Allisson Filipe Lopes Martins1, Ana Paula Gonçalves de Jesus1, Sebastião Silvério de Sousa Neto1, Arthur Wilson Florêncio da Costa1, Carlos Henrique Pereira1, Angélica Ferreira Oton-Leite1, Nilceana Maya Aires de Freitas2, Cláudio Rodrigues Leles1, Elismauro Francisco Mendonça3,4.   

Abstract

OBJECTIVE: To evaluate the occurrence and severity of oral complications, number of radiotherapy (RT) interruptions and quality of life (QoL) in a population of head and neck cancer patients receiving a preventive oral care program (POCP) and photobiomodulation therapy (PBMT).
METHODS: Prospective cohort of 61 head and neck cancer patients undergoing radiochemotherapy were monitored and submitted to a POCP that included oral hygiene and plaque control, removal of infection foci, dental restorations, periodontal therapy, fluorotherapy, oral hydration, and denture removal at night, combined with daily PBMT. Outcomes included occurrence of adverse effects such as severity of oral mucositis (OM) and oral symptoms (pain, solid and fluid dysphagia, odynophagia, dysgeusia), quality of life impacts, and interruptions of radiotherapy (RT) due to symptoms. Disease-free and overall survival rates were evaluated.
RESULTS: There was a significant improvement in oral health conditions between initial assessment and the two longitudinal assessments (p < 0.05), which indicates that the POCP was effective for plaque control and reduction of gingival inflammation. All participants were free of OM at the beginning of the RT regimen and only 45.9% after the 7th session, and few patients ranked the highest score of OM. For all symptoms related to OM, there was a progressive increase of severity until the 14th RT session, which remained stable until the completion of the RT regimen. The same effect was observed for the quality of life measures. Discontinued RT due to OM occurred in only three patients (5%), and the maximum duration was 10 days. The overall survival rate was 77% and disease-free survival was 73.8%. Lower survival time was observed for patients with no response to RT (p < 0.01).
CONCLUSIONS: The findings of this study suggest a positive effect of an oral preventive care program for head and neck cancer patients submitted to RT. The PBMT associated with a rigorous POCP resulted in satisfactory control of oral adverse effects, reduction of quality of life impacts, and interruption of RT regimen due to severe OM.

Entities:  

Keywords:  Head and neck neoplasms; Mucositis; Preventive dentistry; Quality of life; Radiotherapy

Mesh:

Year:  2020        PMID: 31900618     DOI: 10.1007/s00520-019-05283-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  7 in total

Review 1.  Does photobiomodulation therapy improve the postoperative outcomes of tonsillectomy? A systematic review and meta-analysis.

Authors:  José Alcides Almeida de Arruda; Gerhilde Callou Sampaio; Ana Carolina Velasco Pondé de Sena; Lauren Frenzel Schuch; Jaziel Pereira Ribeiro; Manoela Domingues Martins; Tarcília Aparecida Silva; Ricardo Alves Mesquita; Lucas Guimarães Abreu
Journal:  J Lasers Med Sci       Date:  2022-02-16

2.  Body mass index and self-care behaviors related to oral health-related quality of life in patients with oral squamous cell carcinoma within three months posttreatment.

Authors:  Bing-Shen Huang; Ching-Fang Chung; Ya-Lan Chang; Li-Yun Lee; Hsi-Ling Peng; Shu-Ching Chen
Journal:  Support Care Cancer       Date:  2020-09-10       Impact factor: 3.603

3.  Photobiomodulation reduces the impact of radiotherapy on oral health-related quality of life due to mucositis-related symptoms in head and neck cancer patients.

Authors:  Allisson Filipe Lopes Martins; Marília Oliveira Morais; Sebastião Silvério de Sousa-Neto; Ana Paula Gonçalves de Jesus; Tulio Eduardo Nogueira; Marize Campos Valadares; Nilceana Maya Aires Freitas; Aline Carvalho Batista; Cláudio Rodrigues Leles; Elismauro Francisco Mendonça
Journal:  Lasers Med Sci       Date:  2020-10-28       Impact factor: 3.161

4.  The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial).

Authors:  Lodewijckx Joy; Robijns Jolien; Claes Marithé; Evens Stijn; Swinnen Laura; Lenders Hilde; Bortels Sandra; Nassen Wendy; Hilkens Ruth; Raymakers Liesbeth; Snoekx Sylvana; Hermans Sylvia; Mebis Jeroen
Journal:  Support Care Cancer       Date:  2022-03-21       Impact factor: 3.359

Review 5.  Quality Assessment of PBM Protocols for Oral Complications in Head and Neck Cancer Patients: Part 1.

Authors:  Margherita Gobbo; Elisabetta Merigo; Praveen R Arany; René-Jean Bensadoun; Alan Roger Santos-Silva; Luiz Alcino Gueiros; Giulia Ottaviani
Journal:  Front Oral Health       Date:  2022-07-07

Review 6.  Safety and efficacy of photobiomodulation therapy in oncology: A systematic review.

Authors:  René-Jean Bensadoun; Joel B Epstein; Raj G Nair; Andrei Barasch; Judith E Raber-Durlacher; Cesar Migliorati; Marie-Thérèse Genot-Klastersky; Nathaniel Treister; Praveen Arany; Joy Lodewijckx; Jolien Robijns
Journal:  Cancer Med       Date:  2020-10-26       Impact factor: 4.452

7.  Oral and Dental Complications of Radiotherapy for Head and Neck Cancer: Knowledge of Dental Practitioners in Saudi Arabia.

Authors:  Ahmed Shaher Alqahtani; Yousef Alshamrani; Yaser Alhazmi; Esam Halboub
Journal:  Asian Pac J Cancer Prev       Date:  2021-07-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.